✦ LIBER ✦

O5 Progression free survival (PFS) and overall survival (OS) in patients receiving 3 targeted therapies (TTs) for metastatic renal cell carcinoma (mRCC)

✍ Scribed by Iacovelli, R.; Milella, M.; Santoni, M.; Di Lorenzo, G.; Cerbone, L.; Ortega, C.; Masini, C.; Giganti, M.O.; Messina, C.; De Vincenzo, F.; Baratelli, C.; Massari, F.; Boccardo, F.; Sacco, C.; Mosca, A.; Atzori, F.; Lorusso, V.; Valduga, F.; Baldazzi, V.; Cinieri, S.; Primi, F.; Procopio, G.

Book ID: 122815217
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 172 KB
Volume: 11
Category: Article
ISSN: 1569-9056
DOI: 10.1016/S1569-9056(13)60374-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1006 ORAL Prognostic Factors for Progres

1006 ORAL Prognostic Factors for Progression-free Survival (PFS), Overall Survival (OS), and Long-term OS (LT-OS) With Sunitinib in 1,059 Patients, Treated on Clinical Trials, With Metastatic Renal Cell Carcinoma (mRCC)

✍ R.J. Motzer; B. Escudier; R. Bukowski; B.I. Rini; T.E. Hutson; C.H. Barrios; X. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

7124 Association between time to disease

7124 Association between time to disease progression (TDP) endpoints and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)

✍ Delea, T.; Khuu, A.; Kay, A.; Zheng, J.; Baladi, J.F. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

1768 PROGRESSION-FREE AND OVERALL SURVIV

1768 PROGRESSION-FREE AND OVERALL SURVIVAL OF PATIENTS TREATED WITH PRESURGICAL SUNITINIB PRIOR TO CYTOREDUCTIVE NEPHRECTOMY (CN) IN CLEAR CELL SYNCHRONOUS METASTATIC RENAL CELL CARCINOMA (MRCC)

✍ Bex, Axel; Blank, Christian; Chowdhury, Simon; Nichol, David; Peters, John; Hore 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 54 KB

Utilizing pre-therapy clinical schema an

Utilizing pre-therapy clinical schema and initial CT changes to predict progression-free survival in patients with metastatic renal cell carcinoma on VEGF-targeted therapy: A preliminary analysis

✍ Smith, Andrew D.; Shah, Shetal N.; Rini, Brian I.; Lieber, Michael L.; Remer, Er 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 860 KB

Re: Utilizing Pre-Therapy Clinical Schem

Re: Utilizing Pre-Therapy Clinical Schema and Initial CT Changes to Predict Progression-Free Survival in Patients With Metastatic Renal Cell Carcinoma on VEGF-Targeted Therapy: A Preliminary Analysis

✍ Taneja, Samir S. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 109 KB

PCN200 Using A Weibull Parametric Model

PCN200 Using A Weibull Parametric Model for Failure-Time Data to Assess Progression-Free Survival as A Surrogate Endpoint for Overall Survival in A Trial of Patients with Metastatic Renal Cell Carcinoma

✍ Negrier, S.; Bushmakin, A.G.; Cappelleri, J.C.; Charbonneau, C.; Sandin, R.; Mic 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB